Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Plus Therapeutics (NASDAQ:PSTV) through any online brokerage.
Other companies in Plus Therapeutics’s space includes: Kezar Life Sciences Inc (NASDAQ:KZR), Estrella Immunopharma Inc (NASDAQ:ESLA), Aligos Therapeutics Inc (NASDAQ:ALGS), Atossa Therapeutics Inc (NASDAQ:ATOS) and OS Therapies Inc (AMEX:OSTX).
Plus Therapeutics has a consensus price target of $6.75.
The stock price for Plus Therapeutics (NASDAQ: PSTV) is $0.263 last updated February 10, 2026 at 4:25 PM EST.
There are no upcoming dividends for Plus Therapeutics.
Plus Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Plus Therapeutics.
Plus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.